Scott Vold

Scott is an experienced entrepreneur and operator of investor-backed healthcare companies. In August 2021, Scott joined Renalogic as the company’s Chief Commercial Officer. Prior to Renalogic, Scott drove an industry-wide effort to redefine the physician referral management process as Founder, CEO, and Chairman of Fibroblast, Inc., a venture-funded company he led from concept to successful acquisition by Cerner Corporation (NASDAQ: CERN) in October 2020. Scott began his career as an attorney representing Fortune 1000 companies and financial services firms in complex commercial litigation.